Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Kuros Biosciences AG is a biotechnology company based in Switzerland, focused on the development of products for tissue repair and regeneration. Core to its business are biomaterial-based products designed to support bone healing in specific medical conditions. Its product portfolio includes innovative solutions like MagnetOs, used for spinal fusion; it is designed to enhance the body’s natural bone healing process. The company, headquartered in Schlieren, Switzerland, leverages its proprietary technologies to target significant unmet medical needs, positioning itself in the niche market of orthobiologics. Kuros Biosciences emphasizes innovation in biologics and synthetic solutions, aiming for a competitive edge in the healthcare sector.
View stock
VS
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
View stock

Stock highlights

Stock comparison highlights
Stock name
Kuros Biosciences AGJohnson & Johnson
Last price
€22.13$269.51
Currency
EUR
USD
€835M$621B
108.1539.15
€0.19$6.58
0.760.21
0$5.28
02.08%
Sector
HealthHealth
Employees
213138,200
Ticker
€KURN$JNJ
Primary listing
XGATNYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in €KURN or $JNJ on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.